Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of Patients with Hypersensitivity to Platinum Salts and Taxane in Gynecological Cancers: A Cross-Sectional Study by the European Network of Young Gynaecologic Oncologists (ENYGO).
Zwimpfer TA, Bilir E, Gasimli K, Cokan A, Bizzarri N, Razumova Z, Kacperczyk-Bartnik J, Nikolova T, Pletnev A, Kahramanoglu I, Shushkevich A, Strojna A, Theofanakis C, Cicakova T, Vetter M, Montavon C, Morgan G, Heinzelmann-Schwarz V. Zwimpfer TA, et al. Among authors: strojna a. Cancers (Basel). 2024 Mar 14;16(6):1155. doi: 10.3390/cancers16061155. Cancers (Basel). 2024. PMID: 38539490 Free PMC article.
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee.
Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Kurtz JE, et al. Among authors: strojna a. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. Gynecol Oncol. 2021. PMID: 33612336 Review.
The IJGC Editorial Fellowship.
Angeles MA, Bhandoria G, Hsu HC, Jones SEF, Kacperczyk-Bartnik J, Nair N, Noll F, Razumova Z, Strojna A, Wan YL, van Ramshorst GH. Angeles MA, et al. Among authors: strojna a. Int J Gynecol Cancer. 2021 Apr;31(4):644-645. doi: 10.1136/ijgc-2020-002365. Epub 2021 Jan 18. Int J Gynecol Cancer. 2021. PMID: 33462087 No abstract available.
Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilation.
Angeles MA, Bizzarri N, Shushkevich A, Gómez-Hidalgo NR, Theofanakis C, Strojna A, Kacperczyk-Bartnik J, Bilir E, Razumova Z, du Bois A, Cibula D, Concin N, Fotopoulou C, Rodolakis A, Harter P, Ramirez PT. Angeles MA, et al. Among authors: strojna a. Int J Gynecol Cancer. 2022 Apr 4;32(4):468-473. doi: 10.1136/ijgc-2022-003397. Int J Gynecol Cancer. 2022. PMID: 35320115 No abstract available.
Clinician attitude towards sexual counseling in women with gynecologic malignancies: European Network of Young Gynaecological Oncologists (ENYGO) survey.
Kacperczyk-Bartnik J, Nowosielski K, Razumova Z, Bizzarri N, Pletnev A, Lindquist D, Lanner M, Nikolova T, Theofanakis C, Strojna AN, Bartnik P, Gómez-Hidalgo NR, Vlachos DE, Selcuk I, Zalewski K. Kacperczyk-Bartnik J, et al. Among authors: strojna an. Int J Gynecol Cancer. 2022 May 13:ijgc-2021-003309. doi: 10.1136/ijgc-2021-003309. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35568382
ENYGO-IJGC scientific writing and publication course: 2021 meeting summary.
Strojna AN, Kacperczyk-Bartnik J, Angeles MA, Bizzarri N, van Ramshorst GH, Theofanakis C, Bilir E, Razumova Z, Nikolova T, Selcuk I, Wan YL, Zalewski K, Lanner M, Pletnev A, Pareja R, Fotopoulou C, Kehoe S, Bąk J, Ramirez PT. Strojna AN, et al. Int J Gynecol Cancer. 2022 Dec 5;32(12):1599-1605. doi: 10.1136/ijgc-2022-003868. Int J Gynecol Cancer. 2022. PMID: 36418053 Review. No abstract available.
Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: a ENYGO-IJGC Fellows initiative.
Angeles MA, Boria F, Shushkevich AB, Bizzarri N, Theofanakis C, Schivardi G, Kacperczyk-Bartnik J, Strojna AN, Bilir E, Mahner S, Gultekin M, Cibula D, Rodolakis A, Lorusso D, Mirza MR, Fagotti A, Ledermann J, Fotopoulou C, Ramirez PT. Angeles MA, et al. Among authors: strojna an. Int J Gynecol Cancer. 2022 Dec 8:ijgc-2022-004160. doi: 10.1136/ijgc-2022-004160. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 36600507 No abstract available.
Social media ambassadors and collaboration with OncoAlert: a European Network of Young Gynae Oncologists study of comparative Twitter analysis of #ESGO2021 and #ESGO2022.
Bilir E, Ahmed W, Kacperczyk-Bartnik J, Nasser S, Bjerre Trent P, Boria F, Tsibulak I, Chacon E, Martinelli F, Strojna AN, Morgan G, Bizzarri N, Eriksson AG, Theofanakis C. Bilir E, et al. Among authors: strojna an. Int J Gynecol Cancer. 2023 Jun 5;33(6):964-970. doi: 10.1136/ijgc-2023-004371. Int J Gynecol Cancer. 2023. PMID: 37130625
Is it possible to block cancer? The example of #VaginalCancer on Instagram.
Kacperczyk-Bartnik J, Bilir E, Nasser S, Strojna A, Eriksson AGZ. Kacperczyk-Bartnik J, et al. Among authors: strojna a. Int J Gynecol Cancer. 2023 Sep 4;33(9):1488-1489. doi: 10.1136/ijgc-2023-004844. Int J Gynecol Cancer. 2023. PMID: 37591610 No abstract available.
21 results